Heiner Greten

7.1k total citations · 1 hit paper
78 papers, 5.3k citations indexed

About

Heiner Greten is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Heiner Greten has authored 78 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Molecular Biology. Recurrent topics in Heiner Greten's work include Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Cholesterol and Lipid Metabolism (11 papers). Heiner Greten is often cited by papers focused on Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Cholesterol and Lipid Metabolism (11 papers). Heiner Greten collaborates with scholars based in Germany, United States and United Kingdom. Heiner Greten's co-authors include John C. LaRosa, Scott M. Grundy, John J.P. Kastelein, Nanette K. Wenger, James Shepherd, Philip J. Barter, David D. Waters, Charles L. Shear, Jean‐Charles Fruchart and Antonio M. Gotto and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Heiner Greten

76 papers receiving 5.0k citations

Hit Papers

Intensive Lipid Lowering with Atorvastatin in Patients wi... 2005 2026 2012 2019 2005 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heiner Greten Germany 33 3.2k 1.7k 1.2k 875 824 78 5.3k
Tamio Teramoto Japan 38 2.6k 0.8× 1.7k 1.0× 1.5k 1.2× 595 0.7× 878 1.1× 212 5.6k
Jean Bergeron Canada 33 3.3k 1.0× 1.8k 1.1× 1.1k 0.9× 1.1k 1.2× 851 1.0× 81 6.1k
Helmut G. Schrott United States 32 2.7k 0.9× 2.5k 1.5× 1.3k 1.1× 558 0.6× 524 0.6× 59 5.4k
Evan A. Stein United States 27 2.6k 0.8× 1.7k 1.0× 818 0.7× 690 0.8× 400 0.5× 59 4.7k
Jane Armitage United Kingdom 31 2.6k 0.8× 1.2k 0.7× 1.2k 0.9× 721 0.8× 807 1.0× 92 5.7k
Dorothea Collins United States 26 3.4k 1.1× 3.3k 2.0× 1.5k 1.2× 385 0.4× 1.0k 1.2× 39 6.2k
R Češka Czechia 28 3.4k 1.1× 1.3k 0.8× 1.1k 0.9× 1000 1.1× 598 0.7× 174 4.8k
Brian A. Ference United States 29 3.6k 1.1× 2.0k 1.2× 1.6k 1.3× 886 1.0× 804 1.0× 67 6.4k
Gilbert R. Thompson United Kingdom 43 4.1k 1.3× 2.2k 1.3× 1.3k 1.1× 270 0.3× 876 1.1× 172 6.1k
Olivier Descamps Belgium 28 2.9k 0.9× 1.5k 0.9× 1.1k 0.9× 456 0.5× 492 0.6× 86 4.5k

Countries citing papers authored by Heiner Greten

Since Specialization
Citations

This map shows the geographic impact of Heiner Greten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiner Greten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiner Greten more than expected).

Fields of papers citing papers by Heiner Greten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiner Greten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiner Greten. The network helps show where Heiner Greten may publish in the future.

Co-authorship network of co-authors of Heiner Greten

This figure shows the co-authorship network connecting the top 25 collaborators of Heiner Greten. A scholar is included among the top collaborators of Heiner Greten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiner Greten. Heiner Greten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arsenault, Benoît J., Philip J. Barter, David A. DeMicco, et al.. (2014). Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers. PLoS ONE. 9(12). e114519–e114519. 38 indexed citations
2.
LaRosa, John C., Scott M. Grundy, John J.P. Kastelein, John B. Kostis, & Heiner Greten. (2007). Safety and Efficacy of Atorvastatin-Induced Very Low-Density Lipoprotein Cholesterol Levels in Patients With Coronary Heart Disease (a Post Hoc Analysis of the Treating to New Targets [TNT] Study)††Conflicts of interest: Dr. LaRosa has served as a consultant to Pfizer, Inc., New York, New York; Merck Whitehouse Station, New Jersey; Bristol-Myers Squibb, New York, New York; and AstraZeneca, Wilmington, Delaware; and has received lecture fees from Pfizer. Dr. Grundy has consulted with Abbott, Chicago, Illinois; GlaxoSmithKline, Durham, North Carolina, Pfizer, AstraZeneca, and Sanofi-Aventis, Bridgewater, New Jersey; received lecture fees from Merck Schering Plough, Kenilworth, New Jersey; Kos, Edison, New Jersey, Pfizer, GlaxoSmithKline, Lilly, and Bristol-Myers Squibb; and received research support from Abbott and GlaxoSmithKline. Dr. Kastelein has received consulting fees, lecture fees, and grant support from Pfizer, Merck Schering Plough, Bristol-Myers Squibb, and Sankyo, Munich, Germany; Dr. Kostis has served as a consultant to Pfizer, Schering Plough, Berlex, Montville, New Jersey; Taisho, Tokyo, Japan; Forest Laboratories, New York, New York; and Sankyo; received lecture fees from Pfizer, Merck, Bristol-Myers Squibb, AstraZeneca, Sanofi Aventis, and Otsuka, Rockville, Maryland; and received grant support from Pfizer and Schering Plough. Dr. Greten has received consulting and lecturing fees from Pfizer, Merck, Schering Plough, and Kowa Company, Nagoya, Japan.. The American Journal of Cardiology. 100(5). 747–752. 110 indexed citations
3.
Bläker, Michael, Martina Schulz, Andrea Pace, et al.. (2004). The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT. Regulatory Peptides. 118(1-2). 111–117. 12 indexed citations
4.
Merkel, Martin, et al.. (2003). High-Level Baculoviral Expression of Lysosomal Acid Lipase. Humana Press eBooks. 109. 177–186. 1 indexed citations
5.
Evans, D. Gareth, et al.. (1998). Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia. Journal of Molecular Medicine. 76(5). 355–364. 21 indexed citations
6.
Schrenck, T. von, Andreas de Weerth, Thomas Eschenhagen, et al.. (1998). Evidence for CCKB receptors in the guinea-pig kidney: localization and characterization by [125I]gastrin binding studies and by RT-PCR. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(3). 287–292. 13 indexed citations
7.
Sterneck, Martina, Т. С. Калинина, Stephan Günther, et al.. (1998). Functional Analysis of Hbv Genomes From Patients With Fulminant Hepatitis. Hepatology. 28(5). 1390–1397. 47 indexed citations
10.
Schrenck, T. von, et al.. (1993). Characterization of muscarinic receptors on guinea pig gallbladder smooth muscle. Gastroenterology. 105(5). 1341–1349. 19 indexed citations
11.
Rinninger, Franz, et al.. (1993). Selective association of lipoprotein cholesteryl esters with liver plasma membranes. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1166(2-3). 284–299. 21 indexed citations
12.
Kreymann, G., et al.. (1993). Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Critical Care Medicine. 21(7). 1012–1019. 195 indexed citations
13.
Reblin, Tjark, Daniel J. Rader, Ulrike Beisiegel†, Heiner Greten, & H Bryan Brewer. (1992). Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma. Atherosclerosis. 94(2-3). 223–232. 35 indexed citations
14.
Beil, Frank Ulrich, Ulrike Beisiegel†, Heiner Greten, et al.. (1990). Lovastatin versus Bezafibrate: Efficacy, Tolerability, and Effect on Urinary Mevalonate. Cardiology. 77(4). 22–32. 9 indexed citations
15.
Lenz, H. J., Andreas Raedler, Heiner Greten, Wylie Vale, & Jean Rivier. (1988). Stress-Induced Gastrointestinal Secretory and Motor Responses in Rats Are Mediated by Endogenous Corticotropin-Releasing Factor. Gastroenterology. 95(6). 1510–1517. 201 indexed citations
16.
Schmiegel, Wolff, et al.. (1985). Monoclonal antibody-defined human pancreatic cancer-associated antigens.. PubMed. 45(3). 1402–7. 29 indexed citations
17.
Krone, Wilhelm, Dirk Müller‐Wieland, & Heiner Greten. (1985). Effects of Adrenergic Antihypertensive Drugs on Sterol Synthesis in Freshly Isolated Human Mononuclear Leukocytes. Journal of Cardiovascular Pharmacology. 7(6). 1134–1137. 12 indexed citations
18.
Mordasini, R, et al.. (1977). Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients. New England Journal of Medicine. 297(25). 1362–1366. 129 indexed citations
19.
Brown, W. Virgil & Heiner Greten. (1973). Type I hyperlipoproteinaemia. Clinics in Endocrinology and Metabolism. 2(1). 73–80. 4 indexed citations
20.
Greten, Heiner. (1969). Diagnose und Differenzierung von Hyperlipoprotein�mien. Journal of Molecular Medicine. 47(17). 893–896. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026